Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells

By Eunhee Kim, Mi-Suk Kim, Dong-Hun Woo, Y. Shin, Jihye Shin, Nakho Chang, Young-Taek Oh, Hong‐Gyum Kim, Jingeun Rheey, I. Nakano and 5 more. Cancer Cell, 2013

777 citations recorded by the source corpus.

SUMMARY Glioblastoma multiforme (GBM) displays cellular hierarchies harboring a subpopulation of stem-like cells (GSCs). Enhancer of Zeste Homolog 2 (EZH2), the lysine methyl transferase of Polycomb repressive complex 2, mediates transcriptional repression of pro-differentiation genes in both normal and neoplastic stem cells. An oncogenic role of EZH2 as a transcriptional silencer is well established; however, additional functions of EZH2 are incompletely understood. Here we show that EZH2 binds to and methylates STAT3, leading to enhanced STAT3 activity by increased tyrosine phosphorylation of STAT3. The EZH2-STAT3 interaction preferentially occurs in GSCs relative to non-stem bulk tumor cells, and it requires a specific phosphorylation of EZH2. Inhibition of EZH2 reverses the silencing of Polycomb target genes and diminishes STAT3 activity, suggesting therapeutic strategies.

Subfields: Cancer Research, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/389f4c99ac06ef305292b22bcddcedce5bdada34

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

  1. J. Lathia
  2. Jeremy N. Rich

In Molecular Biology

  1. Jeremy N. Rich

Citations in the corpus